RANINasdaq

Rani Therapeutics Holdings, Inc.

Alert me on RANI

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Jul 24 Buy IMRAN MIR A Insider

1 week

−9.0%S&P +1.1%

1 month

+3.3%S&P +3.3%

3 months

−30.9%S&P +3.6%

6 months

Result in51 trading days

Jul 22 Buy Imran Talat Insider

1 week

−5.9%S&P −2.4%

1 month

−5.1%S&P +2.0%

3 months

−27.2%S&P +3.2%

6 months

Result in49 trading days

Jul 22 Sale Javadi Alireza Insider

1 week

−5.9%S&P −2.4%

1 month

−5.1%S&P +2.0%

3 months

−27.2%S&P +3.2%

6 months

Result in49 trading days

Jul 22 Sale Imran Talat Insider

1 week

−5.9%S&P −2.4%

1 month

−5.1%S&P +2.0%

3 months

−27.2%S&P +3.2%

6 months

Result in49 trading days

Oct 28, 2025 Buy IMRAN MIR A Insider

1 week

+25.9%S&P −1.7%

1 month

−14.3%S&P −1.1%

3 months

−32.3%S&P +1.3%

6 months

−53.0%S&P +5.2%

Show all 6

Oct 23, 2025 Sale South Cone Investments Limited Partnership Insider

1 week

−30.6%S&P +1.2%

1 month

−22.0%S&P −1.9%

3 months

−34.0%S&P +3.4%

6 months

−57.4%S&P +7.1%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for RANI

36 held · newest 536 held · newest 2

Loading the filings.

See all 36 filings for RANI

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Signal history

No signal for this ticker yet. A signal is written when insider buying here scores one dot or more.

Stakes

Jun 30, 2026 Schedule 13G, amended

RA Capital Management, L.P.: 9.9%, 11,530,414 shares

Jun 30, 2026 Schedule 13G, amended

Vanguard Capital Management: 4.5%, 5,052,862 shares

May 26, 2026 Schedule 13D, amended

Srinivas Akkaraju: 9.9%, 11,322,961 shares

Mar 27, 2026 Schedule 13G, amended

SymBiosis Capital Partners, LLC: 4.4%, 4,433,620 shares

Mar 31, 2026 Schedule 13G

Vanguard Capital Management: 5.1%, 5,109,368 shares

Mar 13, 2026 Schedule 13G, amended

The Vanguard Group: 0%, 0 shares

Dec 31, 2025 Schedule 13G

AWM Investment Company, Inc.: 9.9%, 9,745,343 shares

Nov 13, 2025 Schedule 13G

SymBiosis Capital Partners, LLC: 6.5%, 6,300,000 shares

Dec 31, 2025 Schedule 13G

The Vanguard Group: 5.2%, 5,109,368 shares

Sep 30, 2025 Schedule 13G, amended

Armistice Capital, LLC: 5%, 2,515,652 shares

Oct 23, 2025 Schedule 13D

Srinivas Akkaraju: 9.9%, 9,882,477 shares

Oct 23, 2025 Schedule 13G

RA Capital Management, L.P.: 9.9%, 9,882,477 shares

Oct 23, 2025 Schedule 13D, amended

MIR A IMRAN: 22.1%, 27,093,552 shares

Oct 16, 2025 Schedule 13G

Raymond Debbane: 10%, 9,825,911 shares

Oct 20, 2025 Schedule 13D, amended

South Cone Investments Limited Partnership: 4.9%, 2,379,194 shares

Schedule 13D is filed within 5 business days of crossing 5 percent by an investor who may seek to influence the company. Schedule 13G is filed by a passive holder, and a large institution has up to 45 days after the quarter end.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.